Wen‐Chi Su

1.6k total citations
47 papers, 1.2k citations indexed

About

Wen‐Chi Su is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Wen‐Chi Su has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Wen‐Chi Su's work include SARS-CoV-2 and COVID-19 Research (10 papers), Influenza Virus Research Studies (7 papers) and interferon and immune responses (7 papers). Wen‐Chi Su is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Influenza Virus Research Studies (7 papers) and interferon and immune responses (7 papers). Wen‐Chi Su collaborates with scholars based in Taiwan, United States and Russia. Wen‐Chi Su's co-authors include King-Song Jeng, Michael M. C. Lai, Michael M. C. Lai, Ti‐Chun Chao, Yung‐Chia Chen, Tzu‐Ping Ko, Chung-Hsin Tseng, Yih‐Leh Huang, Chung‐Yi Wu and Tsai‐Ling Liao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Wen‐Chi Su

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Chi Su Taiwan 20 533 426 246 151 138 47 1.2k
Bin Jia China 20 806 1.5× 308 0.7× 175 0.7× 127 0.8× 66 0.5× 73 1.6k
Xiaoning Si Canada 22 950 1.8× 451 1.1× 504 2.0× 183 1.2× 145 1.1× 30 1.7k
Xuan Huang China 25 505 0.9× 335 0.8× 466 1.9× 121 0.8× 215 1.6× 113 1.7k
Xiaofeng Li China 24 805 1.5× 389 0.9× 458 1.9× 314 2.1× 141 1.0× 166 1.9k
Tingting Liu China 19 386 0.7× 361 0.8× 528 2.1× 206 1.4× 91 0.7× 102 1.5k
Song Huang Switzerland 20 476 0.9× 332 0.8× 136 0.6× 337 2.2× 74 0.5× 53 1.4k
Yujie Ren China 20 580 1.1× 227 0.5× 369 1.5× 512 3.4× 85 0.6× 63 1.4k
Lingbao Kong China 17 521 1.0× 390 0.9× 204 0.8× 424 2.8× 60 0.4× 52 1.5k
Zhenggang Yang China 15 456 0.9× 367 0.9× 191 0.8× 63 0.4× 75 0.5× 34 934
John E. Sagartz United States 26 651 1.2× 373 0.9× 173 0.7× 203 1.3× 461 3.3× 43 1.8k

Countries citing papers authored by Wen‐Chi Su

Since Specialization
Citations

This map shows the geographic impact of Wen‐Chi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Chi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Chi Su more than expected).

Fields of papers citing papers by Wen‐Chi Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Chi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Chi Su. The network helps show where Wen‐Chi Su may publish in the future.

Co-authorship network of co-authors of Wen‐Chi Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Chi Su. A scholar is included among the top collaborators of Wen‐Chi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Chi Su. Wen‐Chi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Wen‐Chi, et al.. (2025). Insights into the protein domains of C-VI TRIM subfamily in viral infection. Frontiers in Cellular and Infection Microbiology. 15. 1573422–1573422.
3.
Lu, Chih‐Hao, Yeh Chen, Wen‐Chi Su, et al.. (2024). Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants. Antiviral Research. 227. 105920–105920. 1 indexed citations
4.
Su, Wen‐Chi, et al.. (2024). Secondhand smoke increases the risk of developing chronic obstructive pulmonary disease. Scientific Reports. 14(1). 7481–7481. 7 indexed citations
5.
Su, Wen‐Chi, King-Song Jeng, Yu‐Chi Chou, et al.. (2023). Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization. Antiviral Research. 220. 105744–105744. 4 indexed citations
6.
Chao, Tai‐Ling, Sui‐Yuan Chang, Chih‐Hao Lu, et al.. (2023). Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry. International Journal of Molecular Sciences. 24(23). 17040–17040. 3 indexed citations
7.
Chiang, Hsiu‐Mei, Yeh Chen, Chung‐Yu Chen, et al.. (2022). Prospects of Coffee Leaf against SARS-CoV-2 Infection. International Journal of Biological Sciences. 18(12). 4677–4689. 13 indexed citations
8.
Tien, Ni, et al.. (2021). Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection. Viruses. 13(7). 1301–1301. 29 indexed citations
9.
Liu, Yuag-Meng, Hui‐Chen Chen, Yi‐Chun Chen, et al.. (2020). miR-1975 serves as an indicator of clinical severity upon influenza infection. European Journal of Clinical Microbiology & Infectious Diseases. 40(1). 141–149. 1 indexed citations
10.
Yu, Wenya, et al.. (2020). Ubiquitination of Zika virus precursor membrane protein promotes the release of viral proteins. Virus Research. 286. 198065–198065. 9 indexed citations
11.
Lai, Hsueh‐Chou, et al.. (2019). The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles. Viruses. 11(11). 1005–1005. 8 indexed citations
12.
Liu, Yuag-Meng, Chung-Hsin Tseng, Yi‐Chun Chen, et al.. (2019). Exosome-delivered and Y RNA-derived small RNA suppresses influenza virus replication. Journal of Biomedical Science. 26(1). 58–58. 63 indexed citations
13.
Su, Wen‐Chi, et al.. (2018). Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development. Frontiers in Microbiology. 9. 1797–1797. 38 indexed citations
14.
Huang, Huey-Lan, et al.. (2016). Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia. OncoTargets and Therapy. Volume 9. 4453–4464. 18 indexed citations
15.
Ho, Mao‐Wang, Dana T. Lin, Hsuan-Ju Chen, et al.. (2016). Association of Head and Neck Cancers in Chronic Osteomyelitis. Medicine. 95(3). e2407–e2407. 2 indexed citations
16.
Chou, Yu‐Chi, et al.. (2015). Variations in genome-wide RNAi screens: lessons from influenza research. PubMed. 5(1). 2–2. 22 indexed citations
17.
Su, Wen‐Chi, et al.. (2012). Attenuation of 40S Ribosomal Subunit Abundance Differentially Affects Host and HCV Translation and Suppresses HCV Replication. PLoS Pathogens. 8(6). e1002766–e1002766. 39 indexed citations
18.
Chen, Yung‐Chia, Wen‐Chi Su, Ti‐Chun Chao, et al.. (2010). Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A. Journal of Virology. 84(16). 7983–7993. 66 indexed citations
19.
Su, Wen‐Chi, Han‐Yi Chou, Ching‐Jin Chang, et al.. (2003). Differential Activation of a C/EBPβ Isoform by a Novel Redox Switch May Confer the Lipopolysaccharide-inducible Expression of Interleukin-6 Gene. Journal of Biological Chemistry. 278(51). 51150–51158. 29 indexed citations
20.
Su, Wen‐Chi, Shu‐Yun Tung, Minjun Yang, & Paula Kuo. (1999). The pilA gene of Xanthomonas campestris pv. citri is required for infection by the filamentous phage cf. Molecular and General Genetics MGG. 262(1). 22–26. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026